Programmed Cell Death in Cancer Progression and Therapy: 615 - Brossura

Libro 39 di 544: Advances in Experimental Medicine and Biology
 
9789048176687: Programmed Cell Death in Cancer Progression and Therapy: 615

Sinossi

Programmed cell death (PCD) plays pivotal roles in tumor progression, cancer therapeutics and resistance of tumor cells to therapy. With the discovery of key mechanisms that are involved in mediating PCD and in promoting resistance to therapy, design of therapeutic approaches for promoting tumor-selective cell death has risen dramatically. With this book, we give a comprehensive overview of the mechanisms that are involved in mediating and regulating PCD in cancer. We also provide a detailed indication of the utility of PCD in cancer therapy. This book will be a valuable resource for researchers investigating the role of PCD in cancer and other diseases, researchers investigating the molecular mechanism of chemotherapeutic agents and drug-resistance in cancer and for physicians using chemotherapeutic agents. Additionally, this book will be a important educational source for PhD students specializing in cell biology, immunology and MD students interested in Oncology and Cancer Therapeutics.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Recensione

From the reviews:

"Programmed cell death (PCD) is an intriguing term that was introduced by Richard Lockshin nearly 45 years ago. ... this book is about PCD with intense focus on apoptosis and the exploitation of PCD for treating cancer. ... All chapters are well edited and thoroughly referenced. The nicety of the book is the use of numerous color figures. In my opinion, both scientists and clinicians, experienced or beginning, will profit from a thoughtful reading of Programmed Cell Death in Cancer Progression and Therapy." (A. A. Philchenkov, Biochemistry (Moscow), Vol. 74 (4), 2009)

Contenuti

Introduction Chapter 1: Cell Death: History and Future by Zahra Zakeri and Richard A. Lockshin Chapter 2: Caspase Mechanisms by Guy S. Salvesen and Stefan J. Riedl Chapter 3: The Mitochondrial Death Pathway by Anas Chalah and Roya Khosravi-Far Chapter 4: Apoptotic Pathways in Tumor Progression and Therapy by Armelle Melet, Keli Song, Octavian Bucur , Zainab Jagani, Alexandra R. Grassian and Roya Khosravi-Far Chapter 5: Therapeutic Targeting of Death Pathways in Cancer - Mechanisms for activating cell death in cancer cells by Ting-Ting Tan and Eileen White Chapter 6: Overcoming Resistance to Apoptosis in Cancer Therapy by Peter Hersey, X.D. Zhang, N. Mhaidat Chapter 7: TRAIL Receptors: Targets for Cancer Therapy by Robin C. Humphreys and Wendy Halpern Chapter 8: Rational Design of Therapeutics Targeting the Bcl-2 Family - Are some cancer cells primed for death but waiting for a final push? by Victoria Del Gaizo Moore and Anthony Letai Chapter 9: Autophagy and Tumor Suppression - Recent advances in understanding the link between autophagic cell death pathways and tumor development by Shani Bialik and Adi Kimchi Chapter 10: Regulation of Programmed Cell Death by the p53 Pathway by Kageaki Kuribayashi and Wafik S. El-Deiry Chapter 11: Regulation Of Programmed Cell Death by Nf-k B and its Role in Tumorigenesis and Therapy by Yongjun Fan, Jui Dutta, Nupur Gupta, Gaofeng Fan and Céline Gélinas Chapter 12: Targeting Proteasomes as Therapy in Multiple Myeloma by Dharminder Chauhan, Teru Hideshima and Kenneth C. Anderson Chapter 13: Histone Deacetylase Inhibitors: Mechanisms and Clinical Significance in Cancer - HDAC inhibitor-induced apoptosis by Sharmila Shankar and Rakesh K. Srivastava Chapter 14: RNA Interference and Cancer: Endogenous Pathways and Therapeutic Approaches by Derek M. Dykxhoorn, Dipanjan Chowdhury, Judy Lieberman Chapter 15:Cancer Stem Cells and Impaired Apoptosis by Zainab Jagani and Roya Khosravi-Far

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Altre edizioni note dello stesso titolo

9781402065538: Programmed Cell Death in Cancer Progression and Therapy: 615

Edizione in evidenza

ISBN 10:  1402065531 ISBN 13:  9781402065538
Casa editrice: Springer Verlag, 2008
Rilegato